SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: cloudy1 who wrote (8580)2/1/1999 10:25:00 PM
From: aknahow  Respond to of 17367
 
I was sticking to M. Murphy picks. I agree others would qualify but they like Cubist are not in his universe of covered companies.

I personally think XOMA is much further ahead of Microcide in "actual potential" use in the area of antibiotic resistance but Microcide is the company Murphy usually mentions in this regard.

He sees some of their products as antibiotics that can overcome resistance while I do not believe he considers Neuprex an antibiotic.